Send me a link:

*Text messaging rates may apply.

 Dow Down 1.31% Nasdaq Down 1.59%

CytRx Corporation (CYTR)

-NasdaqCM
3.28 Down 0.06(1.80%) 1:52PM EDT - Nasdaq Real Time Price
Prev Close:3.34
Open:3.31
Bid:3.28 x 600
Ask:3.29 x 4200
1y Target Est:11.00
Beta:1.37
Next Earnings Date:N/A
Day's Range:3.26 - 3.38
52wk Range:2.00 - 8.35
Volume:366,251
Avg Vol (3m):1,611,420
Market Cap:182.95M
P/E (ttm):N/A
EPS (ttm):-0.95
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTR

Comparison

Symbol% ChgMkt Cap
CYTRDown 1.80%182.95M
LLYDown 2.16%65.66B
NVSDown 1.25%211.89B
SNYUp 1.13%139.39B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):620.97
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.56
Quarterly EPS Est (Jun-14) :-0.20
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate includes aldoxorubicin that has completed Phase IIb clinical trial as a first-line therapy for soft t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback